Congenital Anomalies: Dr. Bertha Soegiarto, Sp.A
Congenital Anomalies: Dr. Bertha Soegiarto, Sp.A
Congenital Anomalies: Dr. Bertha Soegiarto, Sp.A
Introduction
The number of recognizable patterns of malformation has tripled during the last 25 years Drugs, chemicals, environment agents, genetic & non-genetic defects is better appreciated Recognition of prenatal onset of structural defects, mechanism of injury, and possible etiology determine the necessary evaluation The ultimate goal in evaluating a child with congenital defects is making a spesific diagnosis:
Recurrence risk counseling for parents Prognostication Appropriate plan for achievement of the childs potential
Teratogen
Deformation: an alteration in shape or structural of a part that has differentiated normally (oligohydramnion caused club foot) Disruption: structural defect resulting from destruction of a previously normally formed part (porencephalic cyst due to vascular obstruction caused by TORCH infection) Dysplasia: abnormal organization of cells and the structural consequences (hemangioma, melanoma) Sequence: pattern of multiple anomalies that occurs when a single primary defect in early morphogenesis produces multiple anomalies (amniotic band disruption sequence)
Caused by chromosomal and genetic abnormal & teratogen (includes infections, pharmacological, and chemical agents) Isotretinoin embryopathy
Craniofacial abnormal, microtia&/anotia, cardiovascular defects, CNS anomalies, subnormal IQ Child of women who take isotretinoin between 15 days after conception and the end of the 1st trimester have 35% risk
Down Syndrome
First reported by Down in 1886 Incidence of 1 in 660 newborns most common malformation in male Trisomy chromosome 21 :
Full 21 trisomy (94%) 21 trisomy / normal mosaicism (2,4%) Translocation (3,3%)
Edward Syndrome
First recognized in 1960 Trisomy chromosom 18 Second common multiple malformation syndrome Incidence 0,3/100 Female : Male = 3:1
Crouzon Syndrome
Occular proptosis Frontal bossing Hypoplasia maxilla Craniosynostosis complete structural closure by 11 months of age
Prevalence in U.S. 1-2/1000 lives IQ deficit, poor school performance Mild-moderate microcephaly, short palpebral fissure, maxillary hypoplasia, short nose, smooth phitrum within and smooth upper lip Altered palmar crease, small distal phalanges, small 5th finger nails VSD, ASD
Thalidomide Baby
Congenital Toxoplasmosis
Dysmorphogy Approach
Approach toward the evaluation with individual with congenital defects :
Gather information
Family history Prenatal history
Onset of fetal activity Gestational timing Indication for uterine constraint Drugs intake
Birth history
Mode of delivery Size at birth Neonatal adaptation
Interpret the patient anomalies from the view point of developmental anatomy :
Which anomaly of the patients represents the earliest defect of the morphogenesis to determine the time of insult Can all anomalies be explained on the basis of a single problem in morphogenesis? Does the patient have multiple structural defects that appear to be the consequence of multiple defects in 1 or more tissues multiple malformation syndrome
Attempt to arrive at specific diagnosis, confirm when possible and counsel accordingly
Prenatal Diagnosis
Amniocentesis
Risk of many chromosomal abnormal increases with advancing maternal age fetal karyotyping is adviced chorionic villous sampling Done at 15-18 weeks of pregnancy Risk of miscarriage 1:200 Indication :
previous child with trisomy 21 Parental balanced translocation Affected parents with microdeletion syndrome Parental request this is the only way to exclude recurrence from gonadal mosaicism
Nuchal Scan